Thanks Herro, great find.
The one piece of info that was new in that podcast was the confirmation of the Phase 2b trial results being released by Dr Goh at the Euro Cancer Congress on October 1.
That means it will have to be released to the market shortly prior to the presentation. (presumably either Friday 27th September or morning of Monday Oct 1st).
Up to now, all we knew was it would be some time in the 4th Quarter. Meanwhile, the outcome of the ICS testing could come any day.
I agree with some who say ML is less effusive in these type of PR interviews than Martin Rogers was. He's less of a "spruiker" but sounds more scientific and demure and doesn't seem to like to hype it up. OK for now, but going forward we might need a bit more bells and whistles in that area.
Thanks Herro, great find.The one piece of info that was new in...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 53192 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 41048 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |